Mast cells: a novel therapeutic avenue for cardiovascular diseases?
Cardiovascular Research · 29.05.2024 · 120 (7) · 681-698
DOI: 10.1093/cvr/cvae066 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 17.04.2024. Verfasst von Remo Poto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini 5, Naples 80131, Italy. Hauptthemen laut MEDLINE: Mast Cells, Cardiovascular Diseases. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 344 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, TIMING, Campania Bioscience Project.
Abstract (Originalsprache)
Mast cells are tissue-resident immune cells strategically located in different compartments of the normal human heart (the myocardium, pericardium, aortic valve, and close to nerves) as well as in atherosclerotic plaques. Cardiac mast cells produce a broad spectrum of vasoactive and proinflammatory mediators, which have potential roles in inflammation, angiogenesis, lymphangiogenesis, tissue remodelling, and fibrosis. Mast cells release preformed mediators (e.g. histamine, tryptase, and chymase) and de novo synthesized mediators (e.g. cysteinyl leukotriene C4 and prostaglandin D2), as well as cytokines and chemokines, which can activate different resident immune cells (e.g. macrophages) and structural cells (e.g. fibroblasts and endothelial cells) in the human heart and aorta. The transcriptional profiles of various mast cell populations highlight their potential heterogeneity and distinct gene and proteome expression. Mast cell plasticity and heterogeneity enable these cells the potential for performing different, even opposite, functions in response to changing tissue contexts. Human cardiac mast cells display significant differences compared with mast cells isolated from other organs. These characteristics make cardiac mast cells intriguing, given their dichotomous potential roles of inducing or protecting against cardiovascular diseases. Identification of cardiac mast cell subpopulations represents a prerequisite for understanding their potential multifaceted roles in health and disease. Several new drugs specifically targeting human mast cell activation are under development or in clinical trials. Mast cells and/or their subpopulations can potentially represent novel therapeutic targets for cardiovascular disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini 5, Naples 80131, Italy.
- World Allergy Organization (WAO), Center of Excellence (CoE), Via S. Pansini 5, Naples 80131, Italy.
- Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Via S. Pansini 5, Naples 80131, Italy.
- Institute of Experimental Endocrinology and Oncology 'G. Salvatore', National Research Council (CNR), Via S. Pansini 5, Naples 80131, Italy.
- Department of Pathology and the Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, 291 Campus Dr, Stanford, CA, USA.
- Department of Microbiology and Immunology, Stanford University School of Medicine, 291 Campus Dr, Stanford, CA, USA.
ORCID-Profile: Remo Poto, Gianni Marone, Stephen J Galli, Gilda Varricchi
Förderung
- NIAID NIH HHS
- TIMING
- Campania Bioscience Project
- University of Naples Federico II
- NIAID
Zitieren
APA
Poto, R., Marone, G., Galli, S. J., & Varricchi, G. (2024). Mast cells: a novel therapeutic avenue for cardiovascular diseases?. Cardiovascular Research, 120(7), 681-698. https://doi.org/10.1093/cvr/cvae066
Vancouver
Poto R, Marone G, Galli SJ, Varricchi G. Mast cells: a novel therapeutic avenue for cardiovascular diseases?. Cardiovascular Research. 2024;120(7):681-698. doi:10.1093/cvr/cvae066
BibTeX
@article{Poto2024,
author = {Poto, Remo and Marone, Gianni and Galli, Stephen J and Varricchi, Gilda},
title = {Mast cells: a novel therapeutic avenue for cardiovascular diseases?},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {7},
pages = {681--698},
doi = {10.1093/cvr/cvae066}
}
EUVIMED